James V. Caruso, Chief Executive Officer at Cellectar Biosciences, Inc. (CLRB), bought 10,000 shares at $4.99 ($50K) on 2025-07-02, disclosed to the SEC on 2025-07-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CLRB | BUY | 2020-12-28 | $50K | — | Filing → |
| CLRB | BUY | 2020-06-08 | $25K | — | Filing → |
| CLRB | BUY | 2018-11-30 | $2K | — | Filing → |